Randomized control trial of post-dosimetric evaluation between monotherapy with loose seed and hybrid method in combination of strand seed in patients who undergo prostate brachytherapy

Randomized control trial of post-dosimetric evaluation between monotherapy with loose seed and hybrid method in combination of strand seed in patients who undergo prostate brachytherapy - Dosimetric Evaluation between Loose seed and Hybrid method of Prostate Brachytherapy (DELHPB trial)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012780

Enrollment

200

Registered

2014-01-08

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

monotherapy with loose seed Hybrid method in combination with starnd seed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: cT1-3aN0M0, PSA 50ng/mL or less 1. age: 20 years or greater 2. written informed consent

Exclusion criteria

Exclusion criteria: 1. age: less than 20 years 2. inappropriate candidate judged by attending

Design outcomes

Primary

Measure	Time frame
prostate dose (D90, V100, UD30, R100)	—

Secondary

Measure	Time frame
treatment time, seed migration	—

Countries

Japan

Contacts

Public ContactNoriko Yoshioka

Nara Medical University ethical committee

yoshioka-noriko@naramed-u.ac.jp0744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026